Single-cell in situ mapping of glioblastoma and astrocyte cell lines treated with a carbon dot-mediated riluzole nanotherapeutic agent: a live-cell µFTIR and soft X-ray tomography approach
{{output}}
Nanoparticle-based drug carriers offer a promising alternative to conventional cancer therapies by enabling targeted delivery and reducing off-target toxicity. Here, we used synthesised and characterised carbon-based nanoparticles derived from 2-acrylamido-2-m... ...
